Vagus Nerve Stimulation + Rehabilitation for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This trial uses a device that sends electrical signals to a nerve in the neck while patients do exercises. It targets adults with partial spinal cord injuries in the neck area who struggle with arm and hand movement. The electrical signals may help improve how the brain and nerves respond to exercise, aiding recovery.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it excludes those on medication that may interfere with the study. It's best to discuss your specific medications with the trial team.
What data supports the effectiveness of the treatment Vagus Nerve Stimulation + Rehabilitation for Spinal Cord Injury?
Research shows that pairing vagus nerve stimulation (VNS) with rehabilitation can significantly improve motor recovery after spinal cord injury (SCI). Studies in animal models have demonstrated that VNS enhances recovery of forelimb function and strengthens neural connections, suggesting its potential as a beneficial treatment for SCI.12345
Is Vagus Nerve Stimulation safe for humans?
How does vagus nerve stimulation treatment differ from other treatments for spinal cord injury?
Vagus nerve stimulation (VNS) is unique because it involves delivering electrical impulses to the vagus nerve, which can enhance the brain's ability to rewire itself and improve motor recovery when paired with rehabilitation. Unlike other treatments, VNS specifically targets neural plasticity, helping to restore connections in the nervous system and improve motor function after spinal cord injury.123910
Research Team
Radha Korupolu, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Eligibility Criteria
This trial is for individuals at least 12 months post-traumatic cervical spinal cord injury (C8 and above), with some upper limb movement, like pinching. They must meet surgical criteria for VNS implantation. Excluded are those with non-traumatic SCI, vocal cord issues, significant brain injuries, prior vagus nerve damage, certain medications affecting neurotransmitters, other complicating conditions or surgeries, medical or mental instability, or pregnancy.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 18 goal-directed upper extremity rehabilitation therapy sessions with paired or sham VNS over six weeks
Home Exercise Program
Participants engage in a daily, 30-minute home therapy program
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Active VNS (Vagus Nerve Stimulation)
- Arm rehabilitation (Behavioural Intervention)
- Sham VNS (Vagus Nerve Stimulation)
Active VNS is already approved in Canada for the following indications:
- Epilepsy
- Depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
Dr. LaTanya Love
The University of Texas Health Science Center, Houston
Interim President
MD from UT Medical Branch in Galveston
Dr. Jagat Narula
The University of Texas Health Science Center, Houston
Chief Academic Officer since 2023
MD, PhD
MicroTransponder Inc.
Industry Sponsor